Reference
Altinoz MA, et al. Combined presence of three mgmt gene-polymorphisms in a glioblastoma patient, who developed severe myelosuppression following temozolomide chemotherapy. Neuro-Oncology 18 (Suppl. 4): iv40 abstr. P08.05, 2016. Available from: URL: http://doi.org/10.1093/neuonc/now188.138 [abstract] -Turkey
Rights and permissions
About this article
Cite this article
Temozolomide. Reactions Weekly 1633, 667 (2017). https://doi.org/10.1007/s40278-017-24934-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-24934-9